Cargando…

Significant gastrointestinal morbidity after sacrocolpopexy: The incidence and risk factors

OBJECTIVE: This study aimed to quantify the risk of significant gastrointestinal (GI) morbidity after sacrocolpopexy (SCP), and to identify related risk factors. METHODS: A retrospective study was performed of 258 patients who underwent laparotomic SCP for symptomatic pelvic organ prolapse (POP) fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Yu Ri, Kim, Ji Young, Jeon, Myung Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124092/
https://www.ncbi.nlm.nih.gov/pubmed/25105104
http://dx.doi.org/10.5468/ogs.2014.57.4.304
_version_ 1782329581860028416
author Jo, Yu Ri
Kim, Ji Young
Jeon, Myung Jae
author_facet Jo, Yu Ri
Kim, Ji Young
Jeon, Myung Jae
author_sort Jo, Yu Ri
collection PubMed
description OBJECTIVE: This study aimed to quantify the risk of significant gastrointestinal (GI) morbidity after sacrocolpopexy (SCP), and to identify related risk factors. METHODS: A retrospective study was performed of 258 patients who underwent laparotomic SCP for symptomatic pelvic organ prolapse (POP) from November 2008 to August 2013. By the review of medical records, the frequency of significant GI morbidity that resulted in a prolonged initial hospitalization, readmission, or reoperation was assessed. Thereafter, risk factors for significant GI morbidity were assessed using univariate and multivariate analyses. RESULTS: Ten patients (3.9%) were identified as having significant GI morbidity; nine (3.5%) had a prolonged initial hospital stay or were readmitted for the medical treatment of postoperative ileus and 1 (0.4%) underwent reoperation for small bowel obstruction. The occurrence of significant GI morbidity was significantly associated with patient's age and prior laparotomy. By multivariable logistic regression analysis, age (odds ratio [OR], 1.14; 95% confidence interval [CI], 1.01-1.27; P=0.03) and prior laparotomy (OR, 6.82; 95% CI, 1.37-34.07; P=0.02) were found as independent risk factors for significant GI morbidity. CONCLUSION: One in 25 (3.9%) women after SCP experiences significant GI morbidity. Particularly, women with older age and prior laparotomy have a higher risk for significant GI morbidity. This data will aid preoperative counseling for Korean POP patients undergoing SCP.
format Online
Article
Text
id pubmed-4124092
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society
record_format MEDLINE/PubMed
spelling pubmed-41240922014-08-07 Significant gastrointestinal morbidity after sacrocolpopexy: The incidence and risk factors Jo, Yu Ri Kim, Ji Young Jeon, Myung Jae Obstet Gynecol Sci Original Article OBJECTIVE: This study aimed to quantify the risk of significant gastrointestinal (GI) morbidity after sacrocolpopexy (SCP), and to identify related risk factors. METHODS: A retrospective study was performed of 258 patients who underwent laparotomic SCP for symptomatic pelvic organ prolapse (POP) from November 2008 to August 2013. By the review of medical records, the frequency of significant GI morbidity that resulted in a prolonged initial hospitalization, readmission, or reoperation was assessed. Thereafter, risk factors for significant GI morbidity were assessed using univariate and multivariate analyses. RESULTS: Ten patients (3.9%) were identified as having significant GI morbidity; nine (3.5%) had a prolonged initial hospital stay or were readmitted for the medical treatment of postoperative ileus and 1 (0.4%) underwent reoperation for small bowel obstruction. The occurrence of significant GI morbidity was significantly associated with patient's age and prior laparotomy. By multivariable logistic regression analysis, age (odds ratio [OR], 1.14; 95% confidence interval [CI], 1.01-1.27; P=0.03) and prior laparotomy (OR, 6.82; 95% CI, 1.37-34.07; P=0.02) were found as independent risk factors for significant GI morbidity. CONCLUSION: One in 25 (3.9%) women after SCP experiences significant GI morbidity. Particularly, women with older age and prior laparotomy have a higher risk for significant GI morbidity. This data will aid preoperative counseling for Korean POP patients undergoing SCP. Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society 2014-07 2014-07-15 /pmc/articles/PMC4124092/ /pubmed/25105104 http://dx.doi.org/10.5468/ogs.2014.57.4.304 Text en Copyright © 2014 Korean Society of Obstetrics and Gynecology http://creativecommons.org/licenses/by-nc/3.0/ Articles published in Obstet Gynecol Sci are open-access, distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jo, Yu Ri
Kim, Ji Young
Jeon, Myung Jae
Significant gastrointestinal morbidity after sacrocolpopexy: The incidence and risk factors
title Significant gastrointestinal morbidity after sacrocolpopexy: The incidence and risk factors
title_full Significant gastrointestinal morbidity after sacrocolpopexy: The incidence and risk factors
title_fullStr Significant gastrointestinal morbidity after sacrocolpopexy: The incidence and risk factors
title_full_unstemmed Significant gastrointestinal morbidity after sacrocolpopexy: The incidence and risk factors
title_short Significant gastrointestinal morbidity after sacrocolpopexy: The incidence and risk factors
title_sort significant gastrointestinal morbidity after sacrocolpopexy: the incidence and risk factors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124092/
https://www.ncbi.nlm.nih.gov/pubmed/25105104
http://dx.doi.org/10.5468/ogs.2014.57.4.304
work_keys_str_mv AT joyuri significantgastrointestinalmorbidityaftersacrocolpopexytheincidenceandriskfactors
AT kimjiyoung significantgastrointestinalmorbidityaftersacrocolpopexytheincidenceandriskfactors
AT jeonmyungjae significantgastrointestinalmorbidityaftersacrocolpopexytheincidenceandriskfactors